« Glucagon-Like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time? ». Canadian Diabetes & Endocrinology Today, vol. 4, nᵒ 1, mai 2026, p. 5–9, https://doi.org/10.58931/cdet.2026.4149.